Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Meshkov, AN; Stambol'skiĭ, DV; Nikitina, LA; Abdullaev, SM; Bochkov, VN; Tkachuk, VA; Kukharchuk, VV; Malyshev, PP.
Genetic factors of risk of ischemic heart disease development in patients with familial hypercholesterolemia].
Kardiologiia. 2005; 45(7):10-14
Web of Science PubMed


Autor/innen der Med Uni Graz:
Nikitina Liudmila Aleksandrowna

Dimensions Citations:

Plum Analytics:
Ischemic heart disease (IHD) develops in patients with familial hypercholesterolemia (FHC) 15-20 years earlier than in general population. However age of onset of the disease, its clinical manifestations are variable and not completely determined by cholesterol level and class of low density lipoprotein receptor mutations. To elucidate associations of some auxiliary genetic factors -- such as C151565T, C677T, R353Q polymorphisms of glycoprotein IIIa (GPIIIa), methylenetetrahydrofolate reductase (MTHFR) and coagulation factor VII genes, respectively, -- with the presence of IHD in patients with FHC. Patients with clinical diagnosis of heterozygous FHC (n=198) with (n=106) and without (n=92) IHD. Patients with compared with those without IHD had similar frequency of T-allele of MTHFR gene (p=0.519), more often had T-allele of GPIIIa gene (23 and 12.5%, respectively, p=0.009), and less often -- Q-allele of factor VII gene (13 and 21%, respectively, p=0.048). Multifactorial analysis showed that risk of IHD was higher in patients with TT compared with CC genotype of the GPIIIa gene (OR 1.53, 95%CI 1.12-2.3), and lower in patients with RQ and QQ compared with RR genotype of factor VII gene (OR 0.41, 95%CI 0.19-0.75). In patients with FHC polymorphisms in factor VII and GPIIIa genes but not C677T polymorphism of MTHFR gene were associated with the presence of IHD.
Find related publications in this database (using NLM MeSH Indexing)
Adult -
Cholesterol - blood
Factor VII - genetics
Female -
Genotype -
Heterozygote -
Humans -
Hyperlipoproteinemia Type II - blood Hyperlipoproteinemia Type II - complications Hyperlipoproteinemia Type II - genetics
Male -
Methylenetetrahydrofolate Reductase (NADPH2) - genetics
Middle Aged -
Myocardial Ischemia - blood Myocardial Ischemia - etiology Myocardial Ischemia - genetics
Polymorphism, Genetic -
Risk Factors -
Smoking - adverse effects
Time Factors -

Find related publications in this database (Keywords)
ischemic heart disease
gene polymorphisms
glycoprotein IIIa
methylenetetrahydrofolate reductase
factor VIa I
© Meduni Graz Impressum